Private equity firm Warburg Pincus is close to a sale of portfolio company Euromedic International that could fetch up to €900m ($1.3bn), as buyouts of healthcare companies prove resistant to a wider downturn.

News of the potential sale comes after a refinancing of Euromedic International over the New Year. ING’s London-based central and eastern European leveraged finance and sponsor coverage team led the process, while UniCredit also worked on the €365m refinancing.